These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 27930980
21. Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Seta KA, Roth RA. Biochem Biophys Res Commun; 1997 Feb 03; 231(1):167-71. PubMed ID: 9070242 [Abstract] [Full Text] [Related]
22. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme. Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Sakamoto T, Kawase Y, Akiyama H, Taketomi S, Baba S. Endocrinology; 1989 Jan 03; 124(1):496-504. PubMed ID: 2642422 [Abstract] [Full Text] [Related]
23. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Maianti JP, McFedries A, Foda ZH, Kleiner RE, Du XQ, Leissring MA, Tang WJ, Charron MJ, Seeliger MA, Saghatelian A, Liu DR. Nature; 2014 Jul 03; 511(7507):94-8. PubMed ID: 24847884 [Abstract] [Full Text] [Related]
25. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein. Farris W, Leissring MA, Hemming ML, Chang AY, Selkoe DJ. Biochemistry; 2005 May 03; 44(17):6513-25. PubMed ID: 15850385 [Abstract] [Full Text] [Related]
26. Insulin-degrading enzyme is capable of degrading receptor-bound insulin. Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Amano K, Sakamoto T, Kawase Y, Akiyama H, Nagata M. Biochem Biophys Res Commun; 1988 Jan 29; 150(2):605-14. PubMed ID: 3277630 [Abstract] [Full Text] [Related]
27. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. George N, Kumar TP, Antony S, Jayanarayanan S, Paulose CS. Br J Nutr; 2012 Oct 28; 108(8):1410-8. PubMed ID: 22221397 [Abstract] [Full Text] [Related]
28. Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells. Gao W, Eisenhauer PB, Conn K, Lynch JA, Wells JM, Ullman MD, McKee A, Thatte HS, Fine RE. Neurosci Lett; 2004 Nov 16; 371(1):6-11. PubMed ID: 15500957 [Abstract] [Full Text] [Related]
29. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues. Yfanti C, Mengele K, Gkazepis A, Weirich G, Giersig C, Kuo WL, Tang WJ, Rosner M, Schmitt M. Int J Mol Med; 2008 Oct 16; 22(4):421-31. PubMed ID: 18813847 [Abstract] [Full Text] [Related]
30. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance]. Li CZ, Zhang SH, Shu CD, Ren W. Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb 16; 22(2):151-4. PubMed ID: 12390813 [Abstract] [Full Text] [Related]
31. Rat brain insulin degrading enzyme in insulin and thyroid hormones imbalances. Azam M, Gupta BL, Gupta G, Jain S, Baquer NZ. Biochem Int; 1990 Feb 16; 21(2):321-9. PubMed ID: 2206136 [Abstract] [Full Text] [Related]
32. Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats. Taschetto APD, Zimath PL, Silvério R, Dos Santos C, Boschero AC, Dos Santos GJ, Rafacho A. Life Sci; 2021 Jul 15; 277():119509. PubMed ID: 33865877 [Abstract] [Full Text] [Related]
33. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Gan L, Meng ZJ, Xiong RB, Guo JQ, Lu XC, Zheng ZW, Deng YP, Luo BD, Zou F, Li H. Acta Pharmacol Sin; 2015 May 15; 36(5):597-605. PubMed ID: 25891086 [Abstract] [Full Text] [Related]
34. β₂-adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: antagonism by vitamin D₃ and curcumin. Xavier S, Sadanandan J, George N, Paulose CS. Eur J Pharmacol; 2012 Jul 15; 687(1-3):14-20. PubMed ID: 22579915 [Abstract] [Full Text] [Related]
35. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice. Merino B, Fernández-Díaz CM, Parrado-Fernández C, González-Casimiro CM, Postigo-Casado T, Lobatón CD, Leissring MA, Cózar-Castellano I, Perdomo G. Metabolism; 2020 Dec 15; 113():154352. PubMed ID: 32916153 [Abstract] [Full Text] [Related]
37. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Qiu WQ, Folstein MF. Neurobiol Aging; 2006 Feb 15; 27(2):190-8. PubMed ID: 16399206 [Abstract] [Full Text] [Related]
38. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Cordes CM, Bennett RG, Siford GL, Hamel FG. Biochem Pharmacol; 2009 Mar 15; 77(6):1064-73. PubMed ID: 19154729 [Abstract] [Full Text] [Related]
39. The effects of a cafeteria diet on insulin production and clearance in rats. Castell-Auví A, Cedó L, Pallarès V, Blay M, Ardévol A, Pinent M. Br J Nutr; 2012 Oct 15; 108(7):1155-62. PubMed ID: 22152054 [Abstract] [Full Text] [Related]
40. Multiple functions of insulin-degrading enzyme: a metabolic crosslight? Tundo GR, Sbardella D, Ciaccio C, Grasso G, Gioia M, Coletta A, Polticelli F, Di Pierro D, Milardi D, Van Endert P, Marini S, Coletta M. Crit Rev Biochem Mol Biol; 2017 Oct 15; 52(5):554-582. PubMed ID: 28635330 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]